Ridge Ivf Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.44 M
as on 24-10-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 Cr
as on 24-10-2024
- Revenue 15.09%
(FY 2023)
- Profit -10.69%
(FY 2023)
- Ebitda 66.81%
(FY 2023)
- Net Worth 63.97%
(FY 2023)
- Total Assets 18.72%
(FY 2023)
About Ridge Ivf
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.44 M.
The company currently has active open charges totaling ₹1.20 Cr.
Nivesh Khandelwal and Chander Khandelwal serve as directors at the Company.
- CIN/LLPIN
U74900DL2010PTC203361
- Company No.
203361
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ridge Ivf?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Khandelwal  | Director | 31-May-2010 | Current |
| Nivesh Khandelwal | Director | 31-May-2010 | Current |
Financial of Ridge Ivf.
Ridge Ivf Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.09% increase. The company also saw a substantial fall in profitability, with a 10.69% decrease in profit. The company's net worth Soared by an impressive increase of 63.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ridge Ivf?
In 2023, Ridge Ivf had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gouri Hospitals LimitedActive 39 years 6 monthsNivesh Khandelwal and Chander Khandelwal are mutual person
Rose Fields Resort LlpActive 1 year 10 monthsNivesh Khandelwal and Chander Khandelwal are mutual person
- Ridge Healthcare Private LimitedActive 16 years 2 months
Nivesh Khandelwal and Chander Khandelwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Apr 2022 | ₹1.70 M | Open |
Ge Capital Services India Creation Date: 10 Jul 2012 | ₹3.20 M | Open |
Hdfc Bank Limited Creation Date: 17 Nov 2011 | ₹7.14 M | Open |
How Many Employees Work at Ridge Ivf?
Ridge Ivf has a workforce of 6 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ridge Ivf, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ridge Ivf's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
